Literature DB >> 18241689

7. Immunologic lung disease.

Paul A Greenberger1.   

Abstract

The lung is an extremely complex organ and participates in initial responses to inhaled antigens, infectious agents, and irritants or as a response to exposure through the oral, parenteral, or transdermal routes. There can be constriction of the airways or involvement or even destruction of the lung parenchyma, depending on the condition. This review focuses on selected aspects of the pulmonary innate and adaptive immune responses; the new condition World Trade Center cough, which can cause an asthma-like presentation and resemble reactive airways dysfunction syndrome; and the diagnosis and treatment of various immunologic lung conditions. Innate immune responses occur in the acute respiratory distress syndrome and in transfusion-related acute lung injury. Adaptive immune responses involve specialized mucosal and systemic immune responses, lymphocytes, and antibodies and can result in CD4+ TH1 and TH2 phenotypes, such as TH1 for tuberculosis and TH2 for asthma.

Entities:  

Mesh:

Year:  2008        PMID: 18241689     DOI: 10.1016/j.jaci.2007.07.039

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  4 in total

1.  Lymphocytes in the development of lung inflammation: a role for regulatory CD4+ T cells in indirect pulmonary lung injury.

Authors:  Fabienne Venet; Chun-Shiang Chung; Xin Huang; Joanne Lomas-Neira; Yaping Chen; Alfred Ayala
Journal:  J Immunol       Date:  2009-07-29       Impact factor: 5.422

2.  The value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in differentiating pneumonia from upper respiratory tract infection (URTI) in children: a cross-sectional study.

Authors:  Jinghua Wu; Xu Wang; Mingqi Zhou; Guo-Bo Chen; Jing Du; Ying Wang; Chengyin Ye
Journal:  BMC Pediatr       Date:  2021-12-03       Impact factor: 2.125

3.  Different effects of farrerol on an OVA-induced allergic asthma and LPS-induced acute lung injury.

Authors:  Xinxin Ci; Xiao Chu; Miaomiao Wei; Xiaofeng Yang; Qinren Cai; Xuming Deng
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

4.  Tanreqing Injection Attenuates Lipopolysaccharide-Induced Airway Inflammation through MAPK/NF-κB Signaling Pathways in Rats Model.

Authors:  Wei Liu; Hong-Li Jiang; Lin-Li Cai; Min Yan; Shou-Jin Dong; Bing Mao
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-05       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.